<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19432" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chlamydia Pneumonia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gautam</surname>
            <given-names>Jeevan</given-names>
          </name>
          <aff>Maharajgunj Medical Campus</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Krawiec</surname>
            <given-names>Conrad</given-names>
          </name>
          <aff>Penn State College of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jeevan Gautam declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Conrad Krawiec declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19432.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Three species of Chlamydia namely, C. pneumoniae, C. psittaci, and C. trachomatis are known to cause respiratory infections in humans. They are one of the most common causes of community-acquired pneumonia, and can often be difficult to diagnose due to its nonspecific clinical presentation. While serology is preferred for confirmatory laboratory diagnosis, empiric antibiotic therapy on the basis of clinical assessment is sufficient to cure the illness. The clinical course is usually mild and easily treated with appropriate antibiotics. This activity reviews the etiology, epidemiology, clinical presentation, evaluation, management, and other relevant details of chlamydial pneumonia and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the etiology of chlamydial pneumonia.</p></list-item><list-item><p>Outline the appropriate steps in the evaluation of the patients with chlamydial pneumonia.</p></list-item><list-item><p>Summarize the treatment considerations for patients with chlamydial pneumonia.</p></list-item><list-item><p>Explain the importance of interprofessional team strategies for improving care coordination and communication to improve outcomes for patients with chlamydial pneumonia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19432&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19432">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19432.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pneumonia is an infection of lung parenchyma caused by a variety of pathogens&#x000a0;such as&#x000a0;bacteria, viruses, fungi, and parasites.<xref ref-type="bibr" rid="article-19432.r1">[1]</xref>&#x000a0;One type of bacteria includes Chlamydia species. These species consist of <italic toggle="yes">C. pneumoniae, C. psittaci,</italic> and<italic toggle="yes"> C. trachomatis,</italic> which are obligate intracellular bacterial pathogens. They frequently&#x000a0;infect the respiratory tract in humans.<xref ref-type="bibr" rid="article-19432.r2">[2]</xref><xref ref-type="bibr" rid="article-19432.r3">[3]</xref></p>
        <p>Most of the respiratory tract infections (about 70%) caused by <italic toggle="yes">C. pneumoniae</italic> are asymptomatic or only with mild symptoms, but a minority (30%) of them are responsible for more severe respiratory illnesses such as community-acquired pneumonia (CAP) with atypical symptoms, bronchitis and upper respiratory tract infections (URTIs).<xref ref-type="bibr" rid="article-19432.r4">[4]</xref>&#x000a0;In addition, <italic toggle="yes">C. pneumoniae</italic> is involved not only in respiratory infections but also in the pathogenesis of multiple inflammatory conditions including chronic obstructive pulmonary disease (COPD), asthma, lung cancer, neurological disorders such as Alzheimer disease, multiple sclerosis, and schizophrenia as well as atherosclerosis and arthritis.<xref ref-type="bibr" rid="article-19432.r2">[2]</xref>&#x000a0;Thus, the clinician must be able to promptly recognize, evaluate, and treat this condition to avoid its complications.&#x000a0;</p>
        <p>The following activity will provide an overview of the etiology, clinical features, evaluation, and approach to the management of a patient with chlamydial pneumonia.</p>
      </sec>
      <sec id="article-19432.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">C. pneumoniae</italic>, previously known as TWAR, belongs to the genus Chlamydia. The other two chlamydial species infecting humans are <italic toggle="yes">C. psittaci</italic> and <italic toggle="yes">C. trachomatis.</italic>
<italic toggle="yes">C. pneumoniae</italic> and <italic toggle="yes">C. psittaci</italic> cause respiratory tract infections in adults,&#x000a0;and <italic toggle="yes">Chlamydia trachomatis</italic> causes pneumonia mostly in children.<xref ref-type="bibr" rid="article-19432.r3">[3]</xref></p>
        <p>Only 1 serovar or strain of <italic toggle="yes">C. pneumoniae</italic> has been identified to date.<xref ref-type="bibr" rid="article-19432.r3">[3]</xref>&#x000a0;First identified in the conjunctiva of a child in Taiwan in 1965, <italic toggle="yes">C. pneumonia</italic> was then isolated from the respiratory tract from a University of Washington student before being recognized as a major respiratory pathogen in 1983.<xref ref-type="bibr" rid="article-19432.r5">[5]</xref>&#x000a0;<italic toggle="yes">C. pneumoniae</italic> exists in two distinct morphological forms; the elementary body (EB), which is infectious, and the reticulate body (RB), which is metabolically active and replicates after causing cell lysis.<xref ref-type="bibr" rid="article-19432.r2">[2]</xref>&#x000a0;Humans are the only known reservoir of <italic toggle="yes">C. pneumoniae.</italic></p>
        <p><italic toggle="yes">C. pneumoniae</italic> is one of the pathogens commonly involved in community-acquired pneumonia, and it spreads from human to human via respiratory droplets without any known animal reservoir. Transmission via asymptomatic carriers has also been reported. The incubation period can be about 3-4 weeks, which is more than most respiratory infections.<xref ref-type="bibr" rid="article-19432.r3">[3]</xref>&#x000a0;The capacity of the pathogen to survive in aerosols in a humid environment also facilitates its transmission.<xref ref-type="bibr" rid="article-19432.r6">[6]</xref></p>
        <p><italic toggle="yes">C.psittaci</italic> can transmit through contact with infected birds, usually when humans inhale the pathogen present in dried feces of birds. However, human to human transmission can also occur.<xref ref-type="bibr" rid="article-19432.r7">[7]</xref></p>
        <p><italic toggle="yes">C.trachomatis</italic> pneumonia is transmitted from the infected mother&#x02019;s birth canal to the child during childbirth.<xref ref-type="bibr" rid="article-19432.r8">[8]</xref></p>
      </sec>
      <sec id="article-19432.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p><italic toggle="yes">C. pneumoniae</italic> is the most common intracellular bacterium, which is mainly involved in infections of the respiratory tract and sometimes&#x000a0;manifests as extrapulmonary disease.<xref ref-type="bibr" rid="article-19432.r9">[9]</xref>&#x000a0;The majority of the population&#x000a0;becomes exposed to this pathogen throughout their lifetime. It has a 50% antibody prevalence by 20 years of age and 80% by the age of 60&#x000a0;to 70 years, suggesting that the infection is usually asymptomatic, and people are infected and reinfected throughout life.<xref ref-type="bibr" rid="article-19432.r2">[2]</xref>&#x000a0;Seroprevalence is found to be higher in males for the age group &#x0003e;15 years but similar in both sexes under the age of 15 years.<xref ref-type="bibr" rid="article-19432.r6">[6]</xref></p>
        <p><italic toggle="yes">C. pneumoniae</italic> infection can be widespread in the form of an endemic or epidemic. It is known to be a cause of community-acquired pneumonia in up to 20% of the cases. In western countries, the age group of 5&#x000a0;to 15 years has the highest rate of new infections. <italic toggle="yes">C. pneumonia</italic> may sometimes present in a severe form in immunocompromised patients. <italic toggle="yes">C. pneumoniae&#x000a0;</italic>is also attributed to the outbreaks in nursing home acquired pneumonia.<xref ref-type="bibr" rid="article-19432.r9">[9]</xref><xref ref-type="bibr" rid="article-19432.r10">[10]</xref>&#x000a0;Research shows that <italic toggle="yes">C. pneumonia</italic> has&#x000a0;a role in the pathogenesis of asthma in children and adults. Studies have shown that patients with chronic bronchitis show a strong immune response to this organism suggesting the prevalence of chronic <italic toggle="yes">C. pneumonia</italic> in patients with chronic bronchitis. Recent evidence has indicated the association of <italic toggle="yes">C. pneumonia</italic> with atherosclerosis and coronary artery disease as well.<xref ref-type="bibr" rid="article-19432.r9">[9]</xref></p>
        <p><italic toggle="yes">Chlamydia psittaci</italic> is a less prevalent cause of pneumonia, contributing to only about 1% of the cases. Every year, in the United States, the number of cases reported is less than 50. Patients usually have a history of contact with birds. Although all kinds of birds are the main reservoir of this pathogen, usually, pet birds, including parrots and poultry, are the primary source of infection. Human to human transmission can also occur, although rarely.<xref ref-type="bibr" rid="article-19432.r11">[11]</xref></p>
        <p><italic toggle="yes">C. trachomatis</italic> is known to cause pneumonia in infants. Infection is generally acquired perinatally from the birth canal of infected mothers, usually presenting at 3&#x000a0;to 12 weeks of life, sometimes even earlier.<xref ref-type="bibr" rid="article-19432.r8">[8]</xref></p>
      </sec>
      <sec id="article-19432.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The human respiratory tract is susceptible to microbial proliferation whenever the pathogens&#x000a0;overcome the host defense mechanisms (mechanical barrier by hair and mucus, chemical opsonization by the secreted proteins, and immune action by alveolar macrophages).</p>
        <p>The extracellular infectious form of <italic toggle="yes">Chlamydiae</italic>, the elementary body (EB), which is metabolically inactive, enters the respiratory tract via inhalation and then attaches to the mucosal surface. The EB enters the cells via receptor-mediated endocytosis differentiating into&#x000a0;a reticulate body (RB) in the inclusion. RBs are metabolically active, capable of modifying host cell pathways, and replicating within 24 hours post-infection.</p>
        <p>After about 48&#x000a0;to 72 hours, the RBs are finally released as EBs outside the cells by cell lysis and infect the neighboring cells, thus continuing the infection. The organism can escape the endocytic-lysosomal pathway of host cells to remain persistent within tissues under stressful conditions and reactivate when favorable condition resumes. This attributes to the chronic inflammatory state in the host that is often present in <italic toggle="yes">C. pneumonia</italic> infections.<xref ref-type="bibr" rid="article-19432.r12">[12]</xref><xref ref-type="bibr" rid="article-19432.r13">[13]</xref></p>
        <p>Patients reinfected with <italic toggle="yes">C. pneumonia</italic> are reported to have less severe illness than those with evidence of primary infection.<xref ref-type="bibr" rid="article-19432.r14">[14]</xref>&#x000a0;Grossly, <italic toggle="yes">C. pneumonia</italic> causes patchy consolidation of the lung parenchyma as the exudate consisting of RBCs, neutrophils, and fibrin gathers in infected areas.<xref ref-type="bibr" rid="article-19432.r15">[15]</xref></p>
      </sec>
      <sec id="article-19432.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p><italic toggle="yes">Chlamydia</italic> species are gram-negative obligate intracellular bacteria. They depend upon the host cell for adenosine triphosphate (ATP)&#x000a0;required for growth and replication. They are visible under the light microscope after staining the specimen with the Giemsa stain. <italic toggle="yes">Chlamydia</italic> is basophilic and appears as typical cytoplasmic inclusion bodies or as free <italic toggle="yes">Chlamydia</italic> under the microscope.<xref ref-type="bibr" rid="article-19432.r16">[16]</xref></p>
        <p>Electron microscopy of <italic toggle="yes">C. pneumoniae</italic> reveals a characteristic pear-shaped EB surrounded by a periplasmic space, whereas <italic toggle="yes">C. trachomatis</italic> and <italic toggle="yes">C. psittaci</italic> have round EBs.<xref ref-type="bibr" rid="article-19432.r3">[3]</xref></p>
        <p>The organism primarily infects respiratory epithelium, and other cells like vascular endothelial cells, smooth muscle cells, monocytes/macrophages, and atheromatous tissues. Alveolar membrane (AM) plays an important role as a target cell in <italic toggle="yes">Chlamydia</italic>&#x000a0;infection and elicits a marked inflammatory response to the infection by the organism. This includes an increased release of inflammatory cytokines within the alveoli, and the collection of interstitial infiltrates consisting of polymorphonuclear and mononuclear cells. This results in local destructive effects on lung tissue.</p>
        <p>Neutrophilic infiltrations are common in the early phase after infection, but distinct lymphocytic alveolitis has also been observed in those with subacute infections. Because of the intracellular survival of <italic toggle="yes">Chlamydia</italic>, AM may also act as a reservoir for the pathogen causing persistence of&#x000a0;infection.<xref ref-type="bibr" rid="article-19432.r17">[17]</xref></p>
      </sec>
      <sec id="article-19432.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Pneumonia caused by chlamydial species presents atypically with non-specific signs and symptoms. It is usually asymptomatic or manifests with mild to moderate symptoms of respiratory tract infection. It can manifest in a severe form particularly in older adults, immunocompromised patients, or those with chronic health conditions. The incubation period is about 3-4 weeks.</p>
        <p>
<bold>History</bold>
</p>
        <p>Most infections are usually mild, with a characteristic subacute onset, may be difficult to distinguish from other forms of community-acquired pneumonia (CAP) or viral infections, and rarely can have a severe course leading to respiratory failure and death. Infection may take an acute or chronic course, maybe be recurrent (reinfection), or exist in a carrier state.</p>
        <p>Pneumonia usually starts with nonspecific flu-like symptoms of pharyngitis, laryngitis, or sinusitis during which the patients have symptoms such as fever, hoarseness, sore throat, and headache. Mild pneumonia follows in the next 1&#x02013;4 weeks, which is characterized by cough persisting for several weeks. Other symptoms are shortness of breath and muscle pain in the chest due to coughing. Nonspecific symptoms such as anorexia, nausea, gastrointestinal disturbance, and body aches are usually present as well. In severe cases, the patient may present with severe dyspnea, pleurisy, drowsiness, or altered sensorium. Occasionally, presentation mimics meningitis with the complaint of high fever, neck stiffness, and headache with other atypical symptoms.</p>
        <p>In <italic toggle="yes">C. pneumoniae</italic> infections, the patient may have a history of contact with other patients but patients with <italic toggle="yes">C. psittaci</italic> pneumonia classically may provide a history of exposure to the birds or their feces, especially parrots. <italic toggle="yes">C. trachomatis</italic> pneumonia has a subacute onset usually lacking fever and is associated with wheezing and bronchitis in infants. There is usually a history of conjunctivitis associated with the same organism.</p>
        <p>Extra-respiratory acute infections which are less common, include cardiovascular diseases (coronary artery disease, endocarditis, myocarditis, pericarditis) or neurological (encephalitis, meningitis, or Guillain-Barr&#x000e9; syndrome). Association with thyroiditis, erythema nodosum, and importantly, with lower respiratory tract infection and reactive airways disease has also been reported.<xref ref-type="bibr" rid="article-19432.r8">[8]</xref><xref ref-type="bibr" rid="article-19432.r10">[10]</xref><xref ref-type="bibr" rid="article-19432.r18">[18]</xref><xref ref-type="bibr" rid="article-19432.r19">[19]</xref><xref ref-type="bibr" rid="article-19432.r20">[20]</xref>&#x000a0;</p>
        <p>
<bold>Physical Findings</bold>
</p>
        <p>Physical findings are also nonspecific in chlamydial pneumonia. Tachypnea, raised body temperature and signs of upper respiratory tract infections such as pharyngeal congestion without exudate are common. Signs of chronic pharyngitis, middle ear infections (with effusion), and sinusitis may be seen. Pneumonia presents in atypical form as there is a lack of purulent sputum with coughing which is characteristically staccato type, particularly in infants. Auscultatory changes are mild in contrast to the significant changes seen on X-ray of the lungs.</p>
        <p>Wheezing is common, however, coarse crepitations with rhonchi and rales can also be found on auscultation.&#x000a0;Rarely signs of pleural rub and pleural effusions may be present. Signs of other systems involvement i.e. hepatomegaly and splenomegaly may be seen especially in the case of psittacosis. Patients with <italic toggle="yes">C. psittaci</italic> pneumonia may have relative bradycardia and somnolence as well.<xref ref-type="bibr" rid="article-19432.r10">[10]</xref></p>
      </sec>
      <sec id="article-19432.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Initial investigation reports may be non-specific. Therefore, a high degree of clinical suspicion is important for the diagnosis and initiation of appropriate empirical therapy as syndromic management of atypical pneumonia.</p>
        <p>Baseline blood investigations&#x000a0;may include complete blood count (CBC), liver function tests (LFT), renal function tests (RFT), erythrocyte sedimentation rate (ESR), and serum electrolytes. Raised or normal total leukocyte count can be seen, but relative leukopenia is also common. ESR is usually raised. In the case of psittacosis, slightly deranged LFTs and RFTs can be seen. If a patient has a productive cough, then sputum culture with staining is also ordered to rule out the causative bacterium and its resistance. The culture of Chlamydia&#x000a0;from respiratory secretions in special media is possible but difficult. Not all laboratories are equipped to perform this type of specialized testing.&#x000a0;</p>
        <p>Specific diagnostic testing is serological, which is regarded as the gold standard.&#x000a0;Elevation in <italic toggle="yes">C. pneumoniae</italic> IgM titer in a patient with CAP is diagnostic of acute infection, whereas an increase in IgG (by four times)<italic toggle="yes">&#x000a0;</italic>is suggestive of a previous infection. For <italic toggle="yes">C. psittaci</italic> infection, micro-immunofluorescence (MIF) test or polymerase chain reaction (PCR) assay is used to confirm the strong clinical suspicion of a possible diagnosis of psittacosis especially, to distinguish<italic toggle="yes">&#x000a0;</italic>it from other chlamydial species.<xref ref-type="bibr" rid="article-19432.r10">[10]</xref><xref ref-type="bibr" rid="article-19432.r21">[21]</xref>&#x000a0;For <italic toggle="yes">C. trachomatis,</italic> Giemsa stained smears are used to look out for cytoplasmic inclusions or EBs to confirm the diagnosis.<xref ref-type="bibr" rid="article-19432.r22">[22]</xref>&#x000a0;PCR based assay can be done on the nasopharyngeal swab, sputum, or bronchoalveolar lavage but is difficult to implement due to the complexities of performing these tests.<xref ref-type="bibr" rid="article-19432.r23">[23]</xref><xref ref-type="bibr" rid="article-19432.r24">[24]</xref></p>
        <p>On chest radiographs, there are usually atypical and non-specific findings, but alveolar opacities can be seen as well. Patchy consolidations or reticular interstitial opacities may be visible. Pleural effusions are common, and rarely noncardiogenic pulmonary edema is seen. Lobar opacification is uncommon but can be seen in the case of psittacosis.<xref ref-type="bibr" rid="article-19432.r20">[20]</xref></p>
      </sec>
      <sec id="article-19432.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Assessment of the severity of the disease helps to stratify the patients into different treatment groups. The CURB65 scoring is a suitable tool to use in all cases of CAP as it takes clinical history, examination findings, and laboratory value into account and can be used in primary healthcare settings as well. It includes the following elements for assessment:</p>
        <list list-type="bullet">
          <list-item>
            <p>Confusion with new-onset (Abbreviated mental score: &#x0003c; 9 or, orientation to time, place, person: &#x0003c; 3)</p>
          </list-item>
          <list-item>
            <p>Blood Urea Nitrogen: &#x0003e; 19 mg/dL</p>
          </list-item>
          <list-item>
            <p>Respiratory Rate: 30/minute or higher</p>
          </list-item>
          <list-item>
            <p>Blood Pressure: &#x0003c; 90 mmHg (systolic) or &#x0003c;60 mmHg (diastolic)</p>
          </list-item>
          <list-item>
            <p>Age of 65 or more</p>
          </list-item>
        </list>
        <p>Each element carries one point. The patient can be managed according to the outcome score, which ranges from 0-5.</p>
        <list list-type="bullet">
          <list-item>
            <p>Score 0-1: Outpatient treatment; may need further assessment</p>
          </list-item>
          <list-item>
            <p>Score 2: Consider hospitalization to monitor and start therapy</p>
          </list-item>
          <list-item>
            <p>Score 3-5: Hospitalization, possibly intensive care unit (ICU) admission, particularly for a score of 4 or 5<xref ref-type="bibr" rid="article-19432.r25">[25]</xref><xref ref-type="bibr" rid="article-19432.r26">[26]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Empirical Therapy</bold>
</p>
        <p>Because mixed infections with organisms such as pneumococci, legionella, and mycoplasma are common and testing for atypical microorganisms may take time, it is wise to initiate empirical treatment for community-acquired pneumonia. For outpatients, a macrolide (e.g., azithromycin) or a fluoroquinolone (moxifloxacin or levofloxacin) can be prescribed. If the patient has risk factors such as chronic lung conditions, recent use of antibiotics, or admitted to the hospital, then beta-lactam with a macrolide is preferred, but respiratory fluoroquinolones (moxifloxacin, levofloxacin, gemifloxacin) can be given if the patient is allergic to the former regimen.<xref ref-type="bibr" rid="article-19432.r26">[26]</xref></p>
        <p>
<bold>Direct Therapy&#x000a0;</bold>
</p>
        <p>Centers for Disease Control and Prevention (CDC) recommends azithromycin and doxycycline as first-line drugs for the treatment of chlamydial infections; alternatively, levofloxacin, erythromycin, and ofloxacin are considered.<xref ref-type="bibr" rid="article-19432.r27">[27]</xref>&#x000a0;Antibiotics of choice are different for different species.</p>
        <list list-type="bullet">
          <list-item>
            <p>If&#x000a0;<italic toggle="yes">C. pneumoniae</italic> is diagnosed, then azithromycin (500 mg as a loading dose on day 1 and 250 mg maintenance dose for 4 days daily) is given. Tetracycline, clarithromycin, doxycycline, or fluoroquinolones can be used as alternatives.<xref ref-type="bibr" rid="article-19432.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p>If <italic toggle="yes">C. psittaci</italic> is found, then tetracyclines are preferred; doxycycline is given in a dose of 100 mg twice daily for 7-10 days. Macrolides such as azithromycin or erythromycin can be used as an alternative, especially where doxycycline is contraindicated, such as in pregnancy and children below 8 years of age.<xref ref-type="bibr" rid="article-19432.r29">[29]</xref></p>
          </list-item>
          <list-item>
            <p>Erythromycin (50 mg/kg for 14 days in 4 doses) is the drug of choice for <italic toggle="yes">C. trachomatis</italic> pneumonia. Azithromycin can be an alternative. To eradicate the infection in the mother, azithromycin is preferred as a single dose in these cases.<xref ref-type="bibr" rid="article-19432.r30">[30]</xref></p>
          </list-item>
        </list>
        <p>A novel investigational drug, AZD0914, which inhibits DNA gyrase and topoisomerase IV, is reported to have shown efficacy against chlamydial infections comparable to other proven antibiotics such as azithromycin, doxycycline, and levofloxacin.<xref ref-type="bibr" rid="article-19432.r31">[31]</xref></p>
        <p>Other than the antibiotics, antipyretics, fluids, personal hygiene, and rest is advised to the patient to enhance recovery.</p>
      </sec>
      <sec id="article-19432.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>All other causes of atypical pneumonia, such as <italic toggle="yes">Mycoplasma pneumoniae</italic>, <italic toggle="yes">Francisella tularensis</italic>&#x000a0;(tularemia),&#x000a0;<italic toggle="yes">Coxiella burnetii&#x000a0;</italic>(Q fever), and&#x000a0;Legionella, should also be considered when suspecting&#x000a0;<italic toggle="yes">Chlamydia</italic> pneumoniae.<xref ref-type="bibr" rid="article-19432.r10">[10]</xref>&#x000a0;Therefore, a thorough history must be taken along with a clinical examination to rule out other causes of atypical pneumonia in such clinical scenarios.</p>
        <p>Other than pneumonia, the chlamydial species can manifest a broad spectrum of diseases in the patients, such as bronchitis, pharyngitis, sinusitis, or laryngitis. Usually, patients present with atypical and mild symptoms, and they can be misdiagnosed as upper respiratory tract infection, gastroenteritis, or simple sore throat depending upon the presentation. Other differential diagnoses include the following:<xref ref-type="bibr" rid="article-19432.r32">[32]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Bacterial pneumonia</p>
          </list-item>
          <list-item>
            <p>Fungal pneumonia</p>
          </list-item>
          <list-item>
            <p>Viral pneumonia</p>
          </list-item>
          <list-item>
            <p>Tuberculosis</p>
          </list-item>
          <list-item>
            <p>Influenza</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19432.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The clinical outcomes of CAP range from mild illness to a fulminant course with fatal complications. The severity of CAP is also correlated with the immune status and the cardiopulmonary status of the host.<xref ref-type="bibr" rid="article-19432.r10">[10]</xref>&#x000a0;Short-term mortality was found independently associated with demographic variables of patients, comorbidities, abnormalities in lab values, and etiologic agents.<xref ref-type="bibr" rid="article-19432.r33">[33]</xref>&#x000a0;A study showed mortality from <italic toggle="yes">C. pneumonia</italic> to be 9.8%, which was less than the overall mortality of 13.7% due to CAP in the same study.<xref ref-type="bibr" rid="article-19432.r34">[34]</xref></p>
        <p>Overall, the prognosis is good if treatment is started early. The patient with mild symptoms usually recovers within 7-10 days after starting the treatment. The dry cough and general weakness can persist after the disease, slowing the complete remission up to 1 week to 2 months. If neglected, the disease can get worse, leading to complications and even mortality.<xref ref-type="bibr" rid="article-19432.r18">[18]</xref></p>
      </sec>
      <sec id="article-19432.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Usually, the patient recovers without any complications, but immunocompromised patients can develop many fatal complications along with superinfections, including lobar pneumonia, which can worsen into lung access, empyema, or even septic shock.&#x000a0;Some patients can develop severe type 2 respiratory failure and acute respiratory distress syndrome. In addition,&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">C. pneumoniae</italic> is also known to cause some long-term complications such as asthma and reactive arthritis.</p>
          </list-item>
          <list-item>
            <p>In psittacosis, multiple organs can be affected as the illness gets complicated. Manifestations of this can include oliguria, proteinuria, disseminated intravascular coagulation, hemolysis, jaundice, and erythema. Infection can be life-threatening in pregnancy.</p>
          </list-item>
          <list-item>
            <p>Reiter syndrome is a late complication that usually occurs after Chlamydia infection. It is characterized by the triad of reactive arthritis, uveitis, and urethritis.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">C. pneumoniae</italic> infection is reported to accelerate the process of intimal thickening and atherosclerosis in animal models.<xref ref-type="bibr" rid="article-19432.r35">[35]</xref></p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">C. pneumoniae</italic> infection has also been associated with other conditions such as lung cancer, arthritis, erythema nodosum, Alzheimer disease, multiple sclerosis, and sarcoidosis.<xref ref-type="bibr" rid="article-19432.r18">[18]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19432.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Vaccines have not been developed for Chlamydia but there are ways to prevent this infection.&#x000a0;</p>
        <p>Patients should be counseled on refraining themselves from smoking and alcohol. Respiratory precautions should be followed to limit the spread of infection which includes regular hand washing, use of masks, and covering of mouth and nose while coughing or sneezing.<xref ref-type="bibr" rid="article-19432.r36">[36]</xref></p>
        <p>Atypical pneumonia caused by the chlamydial species can be fatal if not promptly addressed, particularly in patients with older age, immunocompromised state, and chronic comorbidities. Such a group of people with presentations suggesting respiratory tract infections should seek immediate care so that appropriate intervention can be done on time.<xref ref-type="bibr" rid="article-19432.r9">[9]</xref>&#x000a0;</p>
        <p><italic toggle="yes">C. psittaci</italic> patients should also consult a veterinarian if they possibly acquired the disease from the contact with infected pet birds so that the birds can be treated after evaluation. The mother of an infant with <italic toggle="yes">C. trachomatis</italic> infection should be evaluated as well and treated along with her sexual partners. Women less than 25 years, and those at increased risk should be encouraged to get screened for chlamydial infections to prevent transmission to the infant.<xref ref-type="bibr" rid="article-19432.r29">[29]</xref><xref ref-type="bibr" rid="article-19432.r22">[22]</xref><xref ref-type="bibr" rid="article-19432.r37">[37]</xref></p>
      </sec>
      <sec id="article-19432.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Presentations of chlamydial pneumonia can be nonspecific. A high degree of clinical suspicion is important to diagnose the condition and treat it promptly. Empirical treatment with appropriate antibiotics usually treats the illness sometimes even before the lab reports are available.</p>
        <p>Vulnerable groups of the population, including older adults, immunocompromised, and those with chronic health conditions should be given special attention as they are at high risk of having complications.</p>
        <p>Possibility of co-infections with other pathogens such as <italic toggle="yes">Pneumococcus, Mycoplasma,</italic> and Legionella should always be considered when treating <italic toggle="yes">C. pneumoniae.</italic></p>
        <p>All women younger than 25 years and those at increased risk of infection should be screened for chlamydial infection.<xref ref-type="bibr" rid="article-19432.r37">[37]</xref></p>
      </sec>
      <sec id="article-19432.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Only with the combined effort of the interprofessional team can efficient patient care be delivered comprehensively. Health care providers should be vigilant for the non-specific signs in atypical pneumonia as the lab investigations usually take time, and the patients are easily treated with appropriate empirical antibiotics. While the condition can be treated in a primary care setting, complicated illness should be referred to higher care facilities or specialists. Clinicians should ensure the patients get all recommended vaccines as mixed infections are common.</p>
        <p>Nursing care providers should ensure hospitalized patients get appropriate care, which includes but not limited to, monitoring vitals, bedside care, medication administration, and assisting patients to recover and regain functionality. The role of pharmacists is important in ascertaining that the right medication with the right dose has been prescribed before they reach the patients.</p>
      </sec>
      <sec id="article-19432.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19432&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19432">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/lung-disease-respiratory-health/chlamydia-pneumonia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=19432">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19432/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19432">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19432.s17">
        <title>References</title>
        <ref id="article-19432.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mackenzie</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The definition and classification of pneumonia.</article-title>
            <source>Pneumonia (Nathan)</source>
            <year>2016</year>
            <volume>8</volume>
            <fpage>14</fpage>
            <pub-id pub-id-type="pmid">28702293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porritt</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Crother</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title><italic>Chlamydia pneumoniae</italic> Infection and Inflammatory Diseases.</article-title>
            <source>For Immunopathol Dis Therap</source>
            <year>2016</year>
            <volume>7</volume>
            <issue>3-4</issue>
            <fpage>237</fpage>
            <page-range>237-254</page-range>
            <pub-id pub-id-type="pmid">30687565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuo</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Grayston</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Chlamydia pneumoniae (TWAR).</article-title>
            <source>Clin Microbiol Rev</source>
            <year>1995</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>451</fpage>
            <page-range>451-61</page-range>
            <pub-id pub-id-type="pmid">8665464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hahn</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Azenabor</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Beatty</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Byrne</surname>
                <given-names>GI</given-names>
              </name>
            </person-group>
            <article-title>Chlamydia pneumoniae as a respiratory pathogen.</article-title>
            <source>Front Biosci</source>
            <year>2002</year>
            <month>Mar</month>
            <day>01</day>
            <volume>7</volume>
            <fpage>e66</fpage>
            <page-range>e66-76</page-range>
            <pub-id pub-id-type="pmid">11861211</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Contini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Seraceni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cultrera</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Castellazzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Granieri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fainardi</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.</article-title>
            <source>Interdiscip Perspect Infect Dis</source>
            <year>2010</year>
            <volume>2010</volume>
            <fpage>273573</fpage>
            <pub-id pub-id-type="pmid">20182626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Theunissen</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Lemmens-den Toom</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Burggraaf</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stolz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Michel</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Influence of temperature and relative humidity on the survival of Chlamydia pneumoniae in aerosols.</article-title>
            <source>Appl Environ Microbiol</source>
            <year>1993</year>
            <month>Aug</month>
            <volume>59</volume>
            <issue>8</issue>
            <fpage>2589</fpage>
            <page-range>2589-93</page-range>
            <pub-id pub-id-type="pmid">8368846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balsamo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maxted</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Midla</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Wohrle</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Edling</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Fish</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Flammer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hyde</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kutty</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Helm</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Oiulfstad</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ritchie</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Stobierski</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Ehnert</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tully</surname>
                <given-names>TN</given-names>
              </name>
            </person-group>
            <article-title>Compendium of Measures to Control Chlamydia psittaci Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017.</article-title>
            <source>J Avian Med Surg</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>262</fpage>
            <page-range>262-282</page-range>
            <pub-id pub-id-type="pmid">28891690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mishra</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Bhardwaj</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaushik</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acute Chlamydia trachomatis respiratory infection in infants.</article-title>
            <source>J Glob Infect Dis</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>216</fpage>
            <page-range>216-20</page-range>
            <pub-id pub-id-type="pmid">21887051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blasi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tarsia</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Arosio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fagetti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Allegra</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Chlamydia pneumoniae.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>4 Suppl 4</volume>
            <fpage>S1</fpage>
            <page-range>S1-S6</page-range>
            <pub-id pub-id-type="pmid">11869264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cunha</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>The atypical pneumonias: clinical diagnosis and importance.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2006</year>
            <month>May</month>
            <volume>12 Suppl 3</volume>
            <fpage>12</fpage>
            <page-range>12-24</page-range>
            <pub-id pub-id-type="pmid">16669925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hogerwerf</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>DE Gier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Baan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>VAN DER Hoek</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis.</article-title>
            <source>Epidemiol Infect</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>145</volume>
            <issue>15</issue>
            <fpage>3096</fpage>
            <page-range>3096-3105</page-range>
            <pub-id pub-id-type="pmid">28946931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abdelrahman</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Belland</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>The chlamydial developmental cycle.</article-title>
            <source>FEMS Microbiol Rev</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>949</fpage>
            <page-range>949-59</page-range>
            <pub-id pub-id-type="pmid">16043254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Pietro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Filardo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Romano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sessa</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title><italic>Chlamydia trachomatis</italic> and <italic>Chlamydia pneumoniae</italic> Interaction with the Host: Latest Advances and Future Prospective.</article-title>
            <source>Microorganisms</source>
            <year>2019</year>
            <month>May</month>
            <day>16</day>
            <volume>7</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">31100923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ekman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Grayston</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Visakorpi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kleemola</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Saikku</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>An epidemic of infections due to Chlamydia pneumoniae in military conscripts.</article-title>
            <source>Clin Infect Dis</source>
            <year>1993</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>420</fpage>
            <page-range>420-5</page-range>
            <pub-id pub-id-type="pmid">8218684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r15">
          <label>15</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Jain</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Vashisht</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yilmaz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bhardwaj</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Pneumonia Pathology</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>31</day>
            <pub-id pub-id-type="pmid">30252372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mordhorst</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Dawson</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Sequelae of neonatal inclusion conjunctivitis and associated disease in parents.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1971</year>
            <month>Apr</month>
            <volume>71</volume>
            <issue>4</issue>
            <fpage>861</fpage>
            <page-range>861-7</page-range>
            <pub-id pub-id-type="pmid">4928532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Redecke</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Dalhoff</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bohnet</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Braun</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Maass</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response.</article-title>
            <source>Am J Respir Cell Mol Biol</source>
            <year>1998</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>721</fpage>
            <page-range>721-7</page-range>
            <pub-id pub-id-type="pmid">9806736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choroszy-Kr&#x000f3;l</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Frej-M&#x00105;drzak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hober</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sarowska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jama-Kmiecik</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Infections caused by Chlamydophila pneumoniae.</article-title>
            <source>Adv Clin Exp Med</source>
            <year>2014</year>
            <season>Jan-Feb</season>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>123</fpage>
            <page-range>123-6</page-range>
            <pub-id pub-id-type="pmid">24596014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaillat</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Clinical manifestations of Chlamydia pneumoniae infections].</article-title>
            <source>Rev Med Interne</source>
            <year>1996</year>
            <volume>17</volume>
            <issue>12</issue>
            <fpage>987</fpage>
            <page-range>987-91</page-range>
            <pub-id pub-id-type="pmid">9008746</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Megran</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Peeling</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Marrie</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Chlamydia pneumoniae pneumonia: An evolving clinical spectrum.</article-title>
            <source>Can J Infect Dis</source>
            <year>1995</year>
            <month>Jul</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>191</fpage>
            <page-range>191-5</page-range>
            <pub-id pub-id-type="pmid">22514396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <article-title>Compendium of measures to control Chlamydia psittaci infection among humans (psittacosis) and pet birds (avian chlamydiosis), 2000. Centers for Disease Control and Prevention.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2000</year>
            <month>Jul</month>
            <day>14</day>
            <volume>49</volume>
            <issue>RR-8</issue>
            <fpage>3</fpage>
            <page-range>3-17</page-range>
            <pub-id pub-id-type="pmid">10914931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyer</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic Procedures to Detect Chlamydia trachomatis Infections.</article-title>
            <source>Microorganisms</source>
            <year>2016</year>
            <month>Aug</month>
            <day>05</day>
            <volume>4</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">27681919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dowell</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Peeling</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Boman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Carlone</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Fields</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Guarner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hammerschlag</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Maass</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Messmer</surname>
                <given-names>TO</given-names>
              </name>
              <name>
                <surname>Talkington</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Tondella</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Zaki</surname>
                <given-names>SR</given-names>
              </name>
              <collab>C. pneumoniae Workshop Participants</collab>
            </person-group>
            <article-title>Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).</article-title>
            <source>Clin Infect Dis</source>
            <year>2001</year>
            <month>Aug</month>
            <day>15</day>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>492</fpage>
            <page-range>492-503</page-range>
            <pub-id pub-id-type="pmid">11462186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pierce</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Elkan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McGowan</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Hodinka</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Comparison of the Idaho Technology FilmArray system to real-time PCR for detection of respiratory pathogens in children.</article-title>
            <source>J Clin Microbiol</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>364</fpage>
            <page-range>364-71</page-range>
            <pub-id pub-id-type="pmid">22116144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lim</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>van der Eerden</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Laing</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boersma</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Karalus</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Town</surname>
                <given-names>GI</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Macfarlane</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.</article-title>
            <source>Thorax</source>
            <year>2003</year>
            <month>May</month>
            <volume>58</volume>
            <issue>5</issue>
            <fpage>377</fpage>
            <page-range>377-82</page-range>
            <pub-id pub-id-type="pmid">12728155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Corr&#x000ea;a</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Lundgren</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Michelin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Figueiredo</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Holanda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gomes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Teixeira</surname>
                <given-names>PJZ</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Athanazio</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>RMD</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>2018 recommendations for the management of community acquired pneumonia.</article-title>
            <source>J Bras Pneumol</source>
            <year>2018</year>
            <season>Sep-Oct</season>
            <volume>44</volume>
            <issue>5</issue>
            <fpage>405</fpage>
            <page-range>405-423</page-range>
            <pub-id pub-id-type="pmid">30517341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zele-Starcevi&#x00107;</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Plecko</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Budimir</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaleni&#x00107;</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>[Choice of antimicrobial drug for infections caused by Chlamydia trachomatis and Chlamydophila pneumoniae].</article-title>
            <source>Acta Med Croatica</source>
            <year>2004</year>
            <volume>58</volume>
            <issue>4</issue>
            <fpage>329</fpage>
            <page-range>329-33</page-range>
            <pub-id pub-id-type="pmid">15700690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Losier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tolbert</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dela Cruz</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Marion</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Atypical Pneumonia: Updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia.</article-title>
            <source>Clin Chest Med</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-58</page-range>
            <pub-id pub-id-type="pmid">28159161</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r29">
          <label>29</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Chu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yarrarapu</surname>
                <given-names>SNS</given-names>
              </name>
              <name>
                <surname>Vaqar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Durrani</surname>
                <given-names>MI</given-names>
              </name>
            </person-group>
            <chapter-title>Psittacosis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>24</day>
            <pub-id pub-id-type="pmid">30855889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r30">
          <label>30</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mohseni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Takov</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <chapter-title>Chlamydia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">30725971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kohlhoff</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Huband</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Hammerschlag</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>58</volume>
            <issue>12</issue>
            <fpage>7595</fpage>
            <page-range>7595-6</page-range>
            <pub-id pub-id-type="pmid">25288086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r32">
          <label>32</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Dasaraju</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <chapter-title>Infections of the Respiratory System</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Baron</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <source>Medical Microbiology</source>
            <edition>4th</edition>
            <publisher-name>University of Texas Medical Branch at Galveston</publisher-name>
            <publisher-loc>Galveston (TX)</publisher-loc>
            <year>1996</year>
            <pub-id pub-id-type="pmid">21413304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gilbert</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fine</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Assessing prognosis and predicting patient outcomes in community-acquired pneumonia.</article-title>
            <source>Semin Respir Infect</source>
            <year>1994</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>140</fpage>
            <page-range>140-52</page-range>
            <pub-id pub-id-type="pmid">7831536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fine</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Carson</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Mutha</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Sankey</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Weissfeld</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>WN</given-names>
              </name>
            </person-group>
            <article-title>Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis.</article-title>
            <source>JAMA</source>
            <year>1996</year>
            <month>Jan</month>
            <day>10</day>
            <volume>275</volume>
            <issue>2</issue>
            <fpage>134</fpage>
            <page-range>134-41</page-range>
            <pub-id pub-id-type="pmid">8531309</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muhlestein</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Hammond</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Trehan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schwobe</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Carlquist</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.</article-title>
            <source>Circulation</source>
            <year>1998</year>
            <month>Feb</month>
            <day>24</day>
            <volume>97</volume>
            <issue>7</issue>
            <fpage>633</fpage>
            <page-range>633-6</page-range>
            <pub-id pub-id-type="pmid">9495296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Razavi</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Mohazzab Torabi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Salamati</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Treatment and prevention of acute respiratory infections among Iranian hajj pilgrims: a 5-year follow up study and review of the literature.</article-title>
            <source>Med J Islam Repub Iran</source>
            <year>2014</year>
            <volume>28</volume>
            <fpage>31</fpage>
            <pub-id pub-id-type="pmid">25250272</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19432.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of Chlamydia trachomatis infection.</article-title>
            <source>Am Fam Physician</source>
            <year>2006</year>
            <month>Apr</month>
            <day>15</day>
            <volume>73</volume>
            <issue>8</issue>
            <fpage>1411</fpage>
            <page-range>1411-6</page-range>
            <pub-id pub-id-type="pmid">16669564</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
